Variables | Number of patients | Univariate | Multivariate | ||
---|---|---|---|---|---|
HR (95% CI) | p Value | HR (95% CI) | p Value | ||
Age(y) | |||||
  ≤ 65 | 178 | reference |  |  |  |
 >65 | 290 | 1.274(0.9313–1.742) | 0.13 |  |  |
Gender | |||||
 Male | 350 | reference |  |  |  |
 Female | 123 | 0.932(0.6665–1.304 | 0.682 |  |  |
Tumor stage | |||||
 stageI/II | 384 | reference |  |  |  |
 stageIII/IV | 85 | 0.999(0.5198–1.992) | 0.9986 |  |  |
T stage | |||||
 T1/T2 | 383 | reference |  | reference |  |
 T3/T4 | 90 | 1.761(1.1188–2.773) | 0.0145* | 1.721(1.23–2.408) | 0.0015** |
N stage | |||||
 N0 | 297 | reference |  |  |  |
 N1 | 126 | 1.025(0.7169–1.466) | 0.8912 |  |  |
 N2 | 40 | 1.373(0.6291–2.995) | 0.4262 |  |  |
 N3 | 4 | 4.473(0.9326–21.456) | 0.0611 |  |  |
 NX | 6 | 2.342(0.7388–7.421) |  |  |  |
M stage | |||||
 M0 | 387 | reference |  | reference |  |
 M1 | 6 | 3.418(1.2156–9.611) | 0.0198* | 3.308(1.349–8.115) | 0.009** |
 MX | 76 | 1.566(1.044–2.348) | 0.0301* | 1.611(1.078–2.401) | 0.0201* |
hsa-let-7d-3p | |||||
 Low expression | 236 | reference |  |  |  |
 High expression | 237 | 0.873(0.6523–1.168) | 0.3593 |  |  |